Literature DB >> 22181832

Relationship between non-alcoholic fatty liver disease and pulmonary function.

D-H Jung1, J-Y Shim, H-R Lee, B-S Moon, B-J Park, Y-J Lee.   

Abstract

BACKGROUND: It has been observed that non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease and insulin resistance. Pulmonary function is also known to be related with cardiovascular disease and metabolic syndrome. AIMS: The objective of this study was to investigate the association between NAFLD and pulmonary function.
METHODS: We performed a cross-sectional study to examine the association of NAFLD based on abdominal sonographic findings and pulmonary function in 2119 Korean men between the ages of 30 and 75. Forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV(1)) were compared according to the presence of NAFLD. Univariate and multivariate logistic regression analyses were conducted to evaluate the relationship of NAFLD with FVC and FEV(1) as pulmonary function tests.
RESULTS: The subjects with NAFLD had lower FVC and FEV(1) than their non-steatotic counterparts, and FVC and FEV(1) gradually decreased according to the grade of hepatic steatosis. After adjusting for age, body mass index, smoking status, blood pressure, fasting plasma glucose, total cholesterol, hypertension, diabetes, triglyceride and high-density lipoprotein cholesterol, the FVC and FEV(1) were found to be inversely associated with the presence of NAFLD.
CONCLUSION: NAFLD was independently associated with reduced pulmonary function, and the severity of NAFLD was inversely correlated with pulmonary function.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2012        PMID: 22181832     DOI: 10.1111/j.1445-5994.2011.02644.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  13 in total

1.  Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease.

Authors:  Doaa El Amrousy; Heba El Ashry; Sara Maher; Salwa Ganna; Samir Hasan
Journal:  Eur J Pediatr       Date:  2021-01-21       Impact factor: 3.183

2.  In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.

Authors:  Jeffrey B Schwimmer; Joel E Lavine; Laura A Wilson; Brent A Neuschwander-Tetri; Stavra A Xanthakos; Rohit Kohli; Sarah E Barlow; Miriam B Vos; Saul J Karpen; Jean P Molleston; Peter F Whitington; Philip Rosenthal; Ajay K Jain; Karen F Murray; Elizabeth M Brunt; David E Kleiner; Mark L Van Natta; Jeanne M Clark; James Tonascia; Edward Doo
Journal:  Gastroenterology       Date:  2016-08-26       Impact factor: 22.682

3.  Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men.

Authors:  Chang-Hee Kwon; Eun-Jung Rhee; Jae-Uk Song; Jung-Tae Kim; Hyon Joo Kwag; Ki-Chul Sung
Journal:  Cardiovasc Diabetol       Date:  2012-04-24       Impact factor: 9.951

4.  Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease.

Authors:  Lei Miao; Li Yang; Li-Sha Guo; Qiang-Qiang Shi; Teng-Fei Zhou; Yang Chen; Huai Zhang; Hui Cai; Zhi-Wei Xu; Shuan-Ying Yang; Hai Lin; Zhe Cheng; Ming-Yang Zhu; Xu Nan; Shuai Huang; Ya-Wen Zheng; Giovanni Targher; Christopher D Byrne; Yu-Ping Li; Ming-Hua Zheng; Cheng-Shui Chen
Journal:  J Clin Transl Hepatol       Date:  2022-01-04

5.  Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study.

Authors:  Tao-Chun Peng; Tung-Wei Kao; Li-Wei Wu; Ying-Jen Chen; Yaw-Wen Chang; Chung-Ching Wang; Yu-Tzu Tsao; Wei-Liang Chen
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese.

Authors:  Li Qin; Weiwei Zhang; Zhen Yang; Yixin Niu; Xiaoyong Li; Shuai Lu; Yin Xing; Ning Lin; Hongmei Zhang; Guang Ning; Jiangao Fan; Qing Su
Journal:  BMC Endocr Disord       Date:  2017-03-22       Impact factor: 2.763

7.  Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).

Authors:  Kyung Soo Hong; Min Cheol Kim; June Hong Ahn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-07

8.  Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010.

Authors:  Sung Woo Moon; Song Yee Kim; Ji Ye Jung; Young Ae Kang; Moo Suk Park; Young Sam Kim; Joon Chang; Jun Soo Ro; Yong-Ho Lee; Sang Hoon Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-28

9.  Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.

Authors:  Jae-Uk Song; Yoonjung Jang; Si-Young Lim; Seungho Ryu; Won Jun Song; Christopher D Byrne; Ki-Chul Sung
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

Review 10.  Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Stanislav Kotlyarov; Aleksei Bulgakov
Journal:  Cells       Date:  2021-11-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.